Top Unlisted Stocks in Q1: Dunamu, Yanolja, Oasis

Analysis of Unlisted Trading Platform 'Jungkwon Plus Bisangjang'
Many Unicorn Companies Rank High...Pharmaceutical and Bio Themes Also Popular

The popular keyword for unlisted stocks in the first quarter of this year was ‘unicorn.’ The pharmaceutical and bio themes, which had been quiet for a while due to weakened investment sentiment, are also gaining momentum.

According to the unlisted trading platform ‘Securities Plus Unlisted’ on the 10th, many unicorn companies such as Dunamu and Yanolja ranked within the ‘TOP 10’ for popular views and trades. The popularity of the pharmaceutical and bio themes, considered steady sellers in the unlisted stock market, remained strong in the first quarter. Initial public offerings (IPOs), which had slowed down temporarily, are regaining momentum mainly among small and medium-sized enterprises.

Global leisure platform company Yanolja demonstrated the strength of unicorns by ranking 2nd in popular views and 7th in popular trades. Yanolja surpassed 4 trillion won in transaction volume in the platform sector last year, fueled by the surge in travel demand ahead of the end of the COVID-19 pandemic. Furthermore, investor expectations were further heightened after receiving approval from the Fair Trade Commission in March to acquire Interpark shares.

Oasis, a fresh food dawn delivery company newly designated as a unicorn by the Ministry of SMEs and Startups last year, ranked 3rd in popular views and 4th in popular trades on Securities Plus Unlisted in the first quarter. Oasis attracted investment sentiment by maintaining a profit trend with an operating profit of 4.8 billion won last year. Curly, a retail tech company ranked 7th in popular views, also drew investors’ attention by exceeding 2 trillion won in sales last year.

The fintech unicorns also continued their strong performance. Viva Republica, which operates the mobile financial platform ‘Toss,’ secured 8th place in popular views on Securities Plus Unlisted in the first quarter, while Dunamu, a blockchain and fintech specialist company, maintained 1st place in both popular views and popular trades.

The pharmaceutical and bio themes showed strength again in the first quarter of this year, following last year. Otom, an X-ray specialist company that won 2nd place in the ‘Draper Aladdin Startup Competition’ at the Middle East’s largest startup event ‘BIBAN 2023’ in March, ranked 9th in popular views and 2nd in popular trades. GNT Pharma, a new drug development company that filed a patent for the stroke drug ‘Nellonemdaz’ injection in January, ranked 4th in popular views and 3rd in popular trades, while Novocellbio, an autoimmune cell therapy R&D company, ranked 5th in popular trades, and Curatis, a vaccine specialist company, ranked 8th in popular trades.

Investor interest in SMEs’ IPOs was also high. Bio venture GI Innovation, which was listed on KOSDAQ in March, ranked 10th in popular trades in the first quarter, and Glam, a manufacturer of architectural display glass that signed a merger agreement with the US JGGC (Jaguar Global Growth Corporation I) and Nasdaq SPAC, ranked 9th in popular trades. APR, a global beauty tech company that attracted 8 billion won in pre-IPO funding in March, ranked 6th in popular trades and 10th in popular views on Securities Plus Unlisted in the first quarter.

This content was produced with the assistance of AI translation services.